Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors
- PMID: 200699
- PMCID: PMC2181898
- DOI: 10.1084/jem.146.6.1693
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors
Abstract
Purified human PMNs secrete plasminogen activator. This secretion is stimulated by Con A and low concentrations of PMA, and is inhibited by low concentrations of glucocorticoids, and by cAMP, actinomycin D, and cycloheximide. In contrast, the release of granule-bound enzymes, such as elastase, is achieved only at higher concentrations of PMA, and is not affected by any of the inhibitors that block plasminogen activator production. These results show that the production of plasminogen activatory by PMNs is controlled by agents that affect inflammations, and that this control is not shared by other lytic enzymes known to be associated with these cells. This suggests a particular role for plasminogen activator in the response pattern of PMNs and also supports the concept, previously developed for macrophages, that the secretion of this enzyme is correlated with cell migration in vivo.
Similar articles
-
Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions.J Exp Med. 1978 Jun 1;147(6):1695-1712. doi: 10.1084/jem.147.6.1695. J Exp Med. 1978. PMID: 210248 Free PMC article.
-
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate.Cell. 1977 Jul;11(3):695-705. doi: 10.1016/0092-8674(77)90086-1. Cell. 1977. PMID: 884740
-
Evidence for regulation of endothelial plasminogen-activating system by polymorphonuclear leukocyte elastase.Thromb Res. 1989 Jun 1;54(5):467-75. doi: 10.1016/0049-3848(89)90216-8. Thromb Res. 1989. PMID: 2772868
-
Neutral proteinases of leucocytes and the inflammatory process.Ciba Found Symp. 1979;(75):381-95. doi: 10.1002/9780470720585.ch21. Ciba Found Symp. 1979. PMID: 399897 Review.
-
[Fibrinolysis and disseminated intravascular coagulation].Rinsho Byori. 1985 Jun;Spec No 63:27-36. Rinsho Byori. 1985. PMID: 2931536 Review. Japanese. No abstract available.
Cited by
-
Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.Br J Exp Pathol. 1988 Oct;69(5):685-95. Br J Exp Pathol. 1988. PMID: 3143395 Free PMC article.
-
Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice.J Exp Med. 1978 Apr 1;147(4):1285-90. doi: 10.1084/jem.147.4.1285. J Exp Med. 1978. PMID: 650154 Free PMC article.
-
Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis.Thromb J. 2023 Jul 31;21(1):82. doi: 10.1186/s12959-023-00526-y. Thromb J. 2023. PMID: 37525162 Free PMC article. Review.
-
Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.J Cell Biol. 1984 Mar;98(3):894-903. doi: 10.1083/jcb.98.3.894. J Cell Biol. 1984. PMID: 6365928 Free PMC article.
-
Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection.Can J Anaesth. 1990 Oct;37(7):762-77. doi: 10.1007/BF03006535. Can J Anaesth. 1990. PMID: 2225293 Review.